Braemar Plc (LON:BMS – Get Free Report)’s share price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 288.25 ($3.86) and traded as high as GBX 293.65 ($3.93). Braemar shares last traded at GBX 290.50 ($3.89), with a volume of 13,238 shares trading hands.
Analyst Ratings Changes
Separately, Canaccord Genuity Group reissued a “buy” rating and issued a GBX 410 ($5.49) price objective on shares of Braemar in a report on Thursday, September 19th.
Check Out Our Latest Stock Report on BMS
Braemar Price Performance
Insider Buying and Selling
In other news, insider James Christopher Duchar Gundy bought 10,000 shares of the business’s stock in a transaction on Thursday, August 8th. The stock was purchased at an average cost of GBX 298 ($3.99) per share, for a total transaction of £29,800 ($39,903.59). In related news, insider James Christopher Duchar Gundy acquired 10,000 shares of the business’s stock in a transaction dated Thursday, August 8th. The stock was bought at an average price of GBX 298 ($3.99) per share, for a total transaction of £29,800 ($39,903.59). Also, insider Tristram Simmonds sold 12,425 shares of the stock in a transaction on Monday, July 8th. The shares were sold at an average price of GBX 300 ($4.02), for a total value of £37,275 ($49,912.96). Corporate insiders own 51.46% of the company’s stock.
About Braemar
Braemar Plc provides shipbroking services in the United Kingdom and internationally. It operates in three segments: Chartering, Investment Advisory, and Risk Advisory. The Chartering segment provides shipbroking services for deep sea tankers, specialized tankers, dry cargo, and offshore; cost-saving solutions; freight consultancy; and a vessel database.
Further Reading
- Five stocks we like better than Braemar
- What is a Stock Market Index and How Do You Use Them?
- CarMax’s Impressive Rally: What Investors Should Watch Next
- With Risk Tolerance, One Size Does Not Fit All
- MarketBeat Week in Review – 9/23 – 9/27
- Dividend Capture Strategy: What You Need to Know
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Braemar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braemar and related companies with MarketBeat.com's FREE daily email newsletter.